Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.

MLA

Kyrtsonis, Marie-Christine, et al. “Prognostic Value of Serum Free Light Chain Ratio at Diagnosis in Multiple Myeloma.” British Journal of Haematology, vol. 137, no. 3, May 2007, pp. 240–43. EBSCOhost, https://doi.org/10.1111/j.1365-2141.2007.06561.x.

APA

Kyrtsonis, M.-C., Vassilakopoulos, T. P., Kafasi, N., Sachanas, S., Tzenou, T., Papadogiannis, A., Galanis, Z., Kalpadakis, C., Dimou, M., Kyriakou, E., Angelopoulou, M. K., Dimopoulou, M. N., Siakantaris, M. P., Dimitriadou, E. M., Kokoris, S. I., Panayiotidis, P., & Pangalis, G. A. (2007). Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. British Journal of Haematology, 137(3), 240–243. https://doi.org/10.1111/j.1365-2141.2007.06561.x

Chicago

Kyrtsonis, Marie-Christine, Theodoros P. Vassilakopoulos, Nicoletta Kafasi, Sotirios Sachanas, Tatiana Tzenou, Argiroula Papadogiannis, Zacharoula Galanis, et al. 2007. “Prognostic Value of Serum Free Light Chain Ratio at Diagnosis in Multiple Myeloma.” British Journal of Haematology 137 (3): 240–43. doi:10.1111/j.1365-2141.2007.06561.x.